Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial

Josafá G Barreto, Claudio G Salgado, Josafá G Barreto, Claudio G Salgado

Abstract

Background: Mycobacterium leprae is the only pathogenic bacteria able to infect peripheral nerves. Neural impairment results in a set of sensitive, motor and autonomic disturbances, with ulcers originating primarily on the hands and feet. The study objectives were to analyze the clinic-epidemiological characteristics of patients attended at one specialized dressing service from a leprosy-endemic region of the Brazilian Amazon and to evaluate the effect of low level laser therapy (LLLT) on wound healing of these patients.

Methods: Clinic-epidemiological evaluation of patients with leprosy sequelae was performed at the reference unit in sanitary dermatology of the state of Pará in Brazil. We conducted anamnesis, identification of the regions affected by the lesions and measurement of ulcer depth and surface area. After that, we performed a randomized clinical trial. Fifty-one patients with ulcers related to leprosy were evaluated, twenty-five of them were randomly assigned to a low level laser therapy group or a control group. Patients were treated 3 times per week for 12 weeks. Outcome measures were ulcer surface area, ulcer depth and the pressure ulcer scale for healing score (PUSH).

Results: Ninety-seven ulcers were identified, with a mean (SD) duration of 97.6 (111.7) months, surface area of 7.3 (11.5) cm2, and depth of 6.0 (6.2) mm. Statistical analysis of the data determined that there were no significant differences in the variables analyzed before and after treatment with low level laser therapy.

Conclusions: Ulcers in patients with leprosy remain a major source of economic and social losses, even many years after they have been cured of M. leprae infection. Our results indicate that it is necessary to develop new and more effective therapeutic tools, as low level laser therapy did not demonstrate any additional benefits to ulcer healing with the parameters used in this study.

Trial registration: The trial was registered at ClinicalTrials.gov as NCT00860717.

Figures

Figure 1
Figure 1
Anatomic distribution of the ulcers on the plantar region. Of 51 plantar ulcers, 33 were on right feet and 18 were on left feet. Ulcers were more common on the areas of the sole that bear weight during walking and standing. The little black circles indicate isolated lesions that were not included in the pictured percentages.
Figure 2
Figure 2
Examples of ulcers in patients with leprosy. (A) Blister formed after walking long distances that later became an ulcer. (B) Fissure on the base of the second toe of the right foot. (C) Right medial malleolus ulcer from a patient with leprosy and HBP. (D) Plantar ulcer on the region of second metatarsal head. (E) Myiasis in a chronic leg ulcer. (F) Chronic ulcer on a lower limb stump.
Figure 3
Figure 3
Flow of participants through the trial.

References

    1. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338–381. doi: 10.1128/CMR.19.2.338-381.2006.
    1. Reinar LM, Forsetlund L, Bjørndal A, Lockwood D. Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database Syst Rev. 2008;3:CD004833.
    1. Salgado CG, Cruz CAV. In: Coleção de estudos regionais sobre os objetivos de desenvolvimento do milênio da Rede de Laboratórios Acadêmicos para Acompanhamento dos Objetivos de Desenvolvimento do Milênio: Região Norte. PNUD; DHS-PUC MINAS; UFPA, editor. Belo Horizonte: PUC Virtual, anexo I-B; 2007. Hanseníase: Análise dos dados epidemiológicos brasileiros em relação ao resto do mundo, com especial ênfase à Região Norte do Brasil; pp. 184–190.
    1. Casos novos de hanseníase por 104 hab. Regiões e unidades federadas. Brasil, 1990 a 2007.
    1. Total de casos novos e percentual de grau de incapacidade avaliada, segundo unidade federada Brasil 2001 a 2007.
    1. V Carta de eliminação da hanseníase: Pará, 2006.
    1. Tunér J, Hode L. The laser therapy handbook. Gränsgesberg, Sweden: Prima Books AB; 2004.
    1. Gonçalves G, Gonçalves A, Padovani CR, Parizotto NA. Promovendo a cicatrização de úlceras hansênicas e não hansênicas com laserterapia: ensaio clínico em unidades ambulatoriais do Sistema Único de Saúde. Hansenol Int. 2000;25:133–142.
    1. Flemming K, Cullum NA. Laser therapy for venous leg ulcers. Cochrane Database Syst Rev. 1999;1:CD001182.
    1. Santos VLCG, Azevedo MAJ, Silva TS, Carvalho VMJ, Carvalho VF. Adaptação transcultural do Pressure Ulcer Scale for Healing (PUSH) para a língua portuguesa. Rev Latino-Am Enfermagem. 2005;13:305–313.
    1. Lang-Stevenson AI, Sharrard WJW, Betts RP, Duckworth T. Neuropathic ulcers of the foot. J Bone Joint Surg. 1985;67-B:438–442.
    1. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ. 2002;324:160–163. doi: 10.1136/bmj.324.7330.160.
    1. Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment. Diabetes Care. 1999;22:692–695. doi: 10.2337/diacare.22.5.692.
    1. Illarramendi X, Buhrer-Sekula S, Sales AM, Bakker MI, Oliveira A, Nery JAC, Oskan L, Wilder-Smith A, Sampaio EP, Sarno EN. High prevalence of vasomotor reflex impairment in newly diagnosed leprosy patients. Eur J Clin Invest. 2005;35:658–665. doi: 10.1111/j.1365-2362.2005.01554.x.
    1. Oda RM, Galan NGA, Opromolla DVA. In: Prevenção de incapacidades e reabilitação em hanseníase. Opromolla DVA, Baccarelli R, editor. Bauru: Instituto Lauro de Souza Lima; 2003. Úlceras de perna na hanseníase; pp. 130–133.
    1. Frade MAC, Cursi IB, Andrade FF, Soares SC, Ribeiro WS, Santos SV, Foss NT. Úlcera de perna: um estudo de casos em Juiz de Fora-MG (Brasil) e região. An Bras Dermatol. 2005;80:41–46. doi: 10.1590/S0365-05962005000100006.
    1. Hopkins JT, McLoda TA, Seegmiller JG, Baxter GD. Low-level laser therapy facilitates superficial wound healing in humans: a triple-blind, sham controlled study. J Athl Train. 2004;39:223–229.
    1. Schindl A, Schindl M, Pernerstorfer-Schon H, Mossbacher U, Schindl L. Low intensity laser irradiation in the treatment of recalcitrant radiation ulcers in patients with breast cancer - long-term results of 3 cases. Photodermatol Photoimmunol Photomed. 2000;16:34–37. doi: 10.1034/j.1600-0781.2000.160109.x.
    1. Schubert V. Effects of phototherapy on pressure ulcer healing in elderly patients after a falling trauma. A prospective, randomized, controlled study. Photodermatol Photoimmunol Photomed. 2001;17:32–38. doi: 10.1034/j.1600-0781.2001.017001032.x.
    1. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg. 2005;31:674–686. doi: 10.1111/j.1524-4725.2005.31612.
    1. Chauhan VS, Pandey SS, Shukla VK. Management of plantar ulcers in Hansen's disease. Int J Low Extrem Wounds. 2003;2:164–167. doi: 10.1177/1534734603257986.
    1. Zimny S, Schatz H, Pfohl M. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers. Exp Clin Endocrinol Diabetes. 2004;112:191–194. doi: 10.1055/s-2004-817932.
    1. Reddy GK. Photobiological basis and clinical role of low-intensity lasers in biology and medicine. J Clin Lasers Med Surg. 2004;22:141–150. doi: 10.1089/104454704774076208.
    1. Pereira AN, Eduardo CP, Matson E, Marques MM. Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med. 2002;31:263–267. doi: 10.1002/lsm.10107.
    1. Medrado AR, Pugliese LS, Reis SR, Andrade ZA. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med. 2003;32:239–244. doi: 10.1002/lsm.10126.
    1. Almeida-Lopes L, Rigau J, Zangaro RA, Guidugli-Neto J, Jaeger MM. Comparison of the low level laser therapy effects on cultured human gingival fibroblasts proliferation using different irradiance and same fluence. Lasers Surg Med. 2001;29:179–184. doi: 10.1002/lsm.1107.
    1. Schindl A, Merwald H, Schindl L, Kaun C, Wojta J. Direct stimulatory effect of low-intensity 670 nm laser irradiation on human endothelial cell proliferation. Br J Dermatol. 2003;148:334–336. doi: 10.1046/j.1365-2133.2003.05070.x.
    1. Grossman N, Schneid N, Reuveni H, Halevy S, Lubart R. 780 nm low power diode laser irradiation stimulates proliferation of keratinocyte cultures: involvement of reactive oxygen species. Lasers Surg Med. 1998;22:212–218. doi: 10.1002/(SICI)1096-9101(1998)22:4<212::AID-LSM5>;2-S.
    1. Rocha Júnior AM, Oliveira RG, Farias RE, Andrade LCF, Aarestrup FM. Modulação da proliferação fibroblástica e da resposta inflamatória pela terapia a laser de baixa intensidade no processo de reparo tecidual. An Bras Dermatol. 2006;81:150–156. doi: 10.1590/S0365-05962006000200006.
    1. Carvalho PT, Mazzer N, Reis FA, Belchior ACG, Silva IS. Analysis of the influence of low-power HeNe laser on the healing of skin wounds in diabetic and non-diabetic rats. Acta Cir Bras. 2006;21:177–183.
    1. Bayat M, Vasheghani MM, Razavi N. Effect of low-level helium-neon laser therapy on the healing of third-degree burns in rats. J Photochem Photobiol B. 2006;83:87–93. doi: 10.1016/j.jphotobiol.2005.12.009.
    1. Silveira PCL, Streck EL, Pinho RA. Evaluation of mitochondrial respiratory chain activity in wound healing by low-level laser therapy. J Photochem Photobiol B. 2007;86:279–282. doi: 10.1016/j.jphotobiol.2006.10.002.
    1. Reddy GK, Stehno-Bittel L, Enwemeka CS. Laser photostimulation accelerates wound healing in diabetic rats. Wound Repair Regen. 2001;9:248–255. doi: 10.1046/j.1524-475x.2001.00248.x.
    1. Lagan KM, Clements BA, McDonough S, Baxter GD. Low intensity laser therapy (830 nm) in the management of minor postsurgical wounds: a controlled clinical study. Lasers Sug Med. 2001;28:27–32. doi: 10.1002/1096-9101(2001)28:1<27::AID-LSM1013>;2-4.
    1. Lagan KM, McKenna T, Withrow A, Johns J, McDonough SM, Baxter GD. Low intensity laser therapy combined phototherapy in the management of chronic venous ulceration: a placebo-controlled study. J Clin Laser Med Surg. 2002;20:109–116. doi: 10.1089/104454702760090173.
    1. Lucas C, Stanborough RW, Freeman CL, de Haan RJ. Efficacy of low-level laser therapy on wound healing in human subjects: a systematic review. Lasers Med Sci. 2000;15:84–93. doi: 10.1007/s101030050053.
    1. Lucas C, Coenen CHM, de Haan RJ. The effect of low level laser therapy (LLLT) on stage III decubitus ulcers (pressure sores); a prospective randomized single blind, multicentre pilot study. Lasers Med Sci. 2000;15:94–100. doi: 10.1007/s101030050054.
    1. Lucas C, van Gemert MJC, de Haan RJ. Efficacy of low-level laser therapy in the management of stage III decubitus ulcers: a prospective, observer-blinded multicentre randomized clinical trial. Lasers Med Sci. 2003;18:72–77. doi: 10.1007/s10103-003-0259-5.
    1. Franek A, Krol P, Kucharzewski M. Does low output laser stimulation enhance the healing of crural ulceration? Some critical remarks. Med Eng Phys. 2002;24:607–615. doi: 10.1016/S1350-4533(02)00112-1.
    1. Taly AB, Sivaraman Nair KP, Murali T, John A. Efficacy of multiwavelength light therapy in the treatment of pressure ulcers in subjects with disorders of the spinal cord: a randomized double-blind controlled trial. Arch Phys Med Rehabil. 2004;85:1657–1661. doi: 10.1016/j.apmr.2004.03.028.
    1. Kopera D, Kokol R, Berger C, Haas J. Low level laser: does it influence wound healing in venous leg ulcers? A randomized, placebo-controlled, doubleblind study. Brit J Dermatol. 2005;152:1368–1370. doi: 10.1111/j.1365-2133.2005.06586.x.
    1. Simon A. Low level laser therapy for wound healing: an update. Edmonton, Canada: Alberta Heritage Foundation for Medical Research; 2004.
    1. Woodruff LD, Bounkeo JM, Brannon WM, Dawes KS, Barham CD, Waddell DL, Enwemeka CS. The efficacy of laser therapy in wound repair: a meta-analysis of the literature. Photomed Laser Surg. 2004;22:241–247. doi: 10.1089/1549541041438623.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj